Skip to content

Clinical trials

Completed Pulmonary Arterial Hypertension trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Status: Completed Country / region: France Clear all

57 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20042
20051
20063
20072
20084
20093
20106
20113
20123
20134
20143
20152
20161
20175
20183
20192
20215
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed57

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion16
United Therapeutics7
Assistance Publique - Hôpitaux de Paris5
Bayer4
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA3
Central Hospital, Nancy, France2
Centre Hospitalier Universitaire de Saint Etienne2
Gilead Sciences2
GlaxoSmithKline2
Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension57
Hypertension, Pulmonary17
Connective Tissue Diseases2
Eisenmenger Complex2
Familial Primary Pulmonary Hypertension2
Heart Defects, Congenital2
Hypertension2
Pulmonary Disease, Chronic Obstructive2
Acquired Immunodeficiency Syndrome1
Cardiovascular Diseases1

Trials

Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.